Medical Marijuana and Cannabidiol Research Expansion Act
Latest action · Dec 2, 2022 Became Public Law No: 117-215.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJul 21, 2022
- Passed HouseJul 26, 2022
- Passed SenateNov 16, 2022
- To the PresidentNov 29, 2022
- Became lawDec 2, 2022Public Law 117-215
Summary
Medical Marijuana and Cannabidiol Research Expansion Act
This act establishes a new, separate registration process to facilitate research on marijuana.
Specifically, the act directs the Drug Enforcement Administration (DEA) to follow procedures specified in the act to register (1) practitioners to conduct marijuana research, and (2) manufacturers to supply marijuana for the research.
The act allows certain registered entities (including institutions of higher education, practitioners, and manufacturers) to manufacture, distribute, dispense, or possess marijuana or cannabidiol (CBD) for the purposes of medical research. Additionally, the act directs the DEA to register manufacturers and distributors of CBD or marijuana for the purpose of commercial production of an approved drug that contains marijuana or its derivative.
Finally, the act includes various other provisions, including provisions that
- require the DEA to assess whether there is an adequate and uninterrupted supply of marijuana for research purposes;
- prohibit the Department of Health and Human Services (HHS) from reinstating the interdisciplinary review process for marijuana research;
- allow physicians to discuss the potential harms and benefits of marijuana and its derivatives (including CBD) with patients; and
- require HHS, in coordination with the National Institutes of Health and relevant federal agencies, to report on the therapeutic potential of marijuana for various conditions such as epilepsy, as well as the impact on adolescent brains and on the ability to operate a motor vehicle.
Recorded votes 1
Newest first. Open one to see how every member voted.
| Roll call | Question | Result | Date |
|---|---|---|---|
| House 392 | On Motion to Suspend the Rules and Pass, as Amended | Passed325–95 | Jul 26, 2022 |
Cosponsors 10
Members who signed on, in the order they did. Signatures ran from Jul 21, 2022 to Jul 22, 2022; 6 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-MD | Andy Harris | Original | Jul 21, 2022 |
| R-OH | David P. Joyce | Original | Jul 21, 2022 |
| D-CO | Ed Perlmutter | Original | Jul 21, 2022 |
| D-DC | Eleanor Holmes Norton | Original | Jul 21, 2022 |
| R-VA | H. Morgan Griffith | Original | Jul 21, 2022 |
| R-SC | Nancy Mace | Original | Jul 21, 2022 |
| D-CA | Barbara Lee | Jul 22, 2022 | |
| D-NH | Chris Pappas | Jul 22, 2022 | |
| D-MI | Debbie Dingell | Jul 22, 2022 | |
| D-TN | Steve Cohen | Jul 22, 2022 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Jul 21, 2022 |
| House | Judiciary Committee | Referred Jul 21, 2022 |
Actions 15
Everything that happened, newest first.
- Dec 2, 2022Signed by President.
- Dec 2, 2022Became Public Law No: 117-215.
- Nov 29, 2022Presented to President.
- Nov 17, 2022Message on Senate action sent to the House.
- Nov 16, 2022Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote. (consideration: CR S6746-6747)
- Jul 27, 2022Received in the Senate, read twice.
- Jul 26, 2022Mr. Pallone moved to suspend the rules and pass the bill, as amended.
- Jul 26, 2022Considered under suspension of the rules. (consideration: CR H7120-7124)
- Jul 26, 2022DEBATE - The House proceeded with forty minutes of debate on H.R. 8454.
- Jul 26, 2022At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
- Jul 26, 2022Considered as unfinished business. (consideration: CR H7145-7146)
- Jul 26, 2022Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 325 - 95 (Roll no. 392). (text: CR H7120-7122)
- Jul 26, 2022Motion to reconsider laid on the table Agreed to without objection.
- Jul 21, 2022Introduced in House
- Jul 21, 2022Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In the Congressional Record 3
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S6736, S6746 | Charles E. Schumer D-NY | Nov 16, 2022 |
| House | Debate and remarks H7120–H7124Text printed H7120–H7122Recorded votes H7145enactLists H7146Votes recorded by proxy on H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion ActNotices H7163Estimated budget effects of H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act | Andy Harris R-MD, Anna G. Eshoo D-CA, Earl Blumenauer D-OR, Earl L. "Buddy" Carter R-GA, Frank Pallone, Jr. D-NJ, H. Morgan Griffith R-VA, John A. Yarmuth D-KY | Jul 26, 2022 |
| House | Lists H7066H.R. 8454–8484 | — | Jul 21, 2022 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 168, no. 121, July 21, 2022, page H7066.
CRS reports 2
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 2
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| IF12270 | The Federal Status of Marijuana and the Policy Gap with States | Resource | Mar 10, 2026 |
| R47910 | The Restoring Hope for Mental Health and Well-Being Act of 2022 (Division FF, Title I of P.L. 117-328, the Consolidated Appropriations Act, 2023): Section-by-Section Summary | Report | Jan 29, 2024 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 253 | Cannabidiol and Marihuana Research Expansion Act | Related bill | Mar 28, 2022 |
Titles 6
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To expand research on cannabidiol and marijuana, and for other purposes.
- Short Titles as Passed Senate
- Medical Marijuana and Cannabidiol Research Expansion Act
- Short Titles as Enacted
- Medical Marijuana and Cannabidiol Research Expansion Act
- Short Title(s) as Introduced
- Medical Marijuana and Cannabidiol Research Expansion Act
- Short Title(s) as Passed House
- Medical Marijuana and Cannabidiol Research Expansion Act
- Short Titles from ENR (Enrolled) bill text
- Medical Marijuana and Cannabidiol Research Expansion Act
Subjects
Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.
- Alternative treatments
- Congressional oversight
- Crime and Law Enforcement
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Health personnel
- Licensing and registrations
- Medical research
- Public-private cooperation
- Research administration and funding
Text 4
Each version as it was printed, newest first.
- —Enrolled Bill
- Jul 27, 2022Received in Senate
- Jul 26, 2022Engrossed in House
- Jul 21, 2022Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.